Skip to main content
. Author manuscript; available in PMC: 2013 Sep 6.
Published in final edited form as: BioDrugs. 2009;23(3):137–153. doi: 10.2165/00063030-200923030-00001

Table 1.

Env immunogen designs and their effect on neutralizing antibody responses

Immunogen Design Concept Immunogens Tested Result References
Centralized Sequences To reduce the genetic distance between immunogens and primary isolates to elicit a more cross reactive response Group M Consensus Increased Breadth of NAb Response [37, 38]
Subtype B Consensus Increased NAb Potency Over Wild type Sequences [41]
Subtype C Consensus No Appreciable Increase Nab Response [39]
Ancestral B No Appreciable Increase Nab Response [40]
Ancestral C No Appreciable Increase Nab Response [39]
Variable Loop Deletions To make functionally important domains more accessible V1/V2, V3, & V4 Deletions No Appreciable Increase Nab Response [48, 52, 53]
V2 Deletions Increased potency and small increases in breadth of NAb Response [49, 51, 52, 124]
Glycosylation Mutants To shield irrelevant domains or expose important domains Hyperglycosylation Elimination of unwanted Ab specificities No improvement on overall NAb [61, 62]
Targeted deletion Increased breadth and potency of NAb response is some isolates, no effect in others [6366]
Envelope Trimers To better mimic the natural state of functional trimer Eliminate Env cleavage site Study and Isolate Dependent [67, 68]
Stabilized intermolecular interactions Inconsistent increases in potency of NAb titers to homologous isolates
Env trimerized with heterologous motifs Increased potency of NAb Response [69, 70, 72]
Epitope Grafting To make a neutralizable epitope more immunogenic when presented in a different context MPER Grafts No increases in NAbs with specificity for graft [76, 77]